Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: An open-label pilot study

被引:67
作者
Martin, Donel M. [1 ]
Alonzo, Angelo [1 ]
Mitchell, Philip B. [1 ]
Sachdev, Perminder [2 ]
Galvez, Veronica [3 ,4 ]
Loo, Colleen K. [1 ,5 ]
机构
[1] Univ New S Wales, Black Dog Inst, Sch Psychiat, Sydney, NSW, Australia
[2] Prince Wales Hosp, Inst Neuropsychiat, Sydney, NSW, Australia
[3] Bellvitge Univ Hosp, Mood Disorders Clin & Res Unit, Dept Psychiat, Bellvitge Univ Hosp, Spain
[4] Bellvitge Biomed Res Inst IDIBELL, Neurosci Grp, Barcelona, Spain
[5] St George Hosp, Sydney, NSW, Australia
基金
英国医学研究理事会;
关键词
Transcranial direct current stimulation; Depression; Montage; Effectiveness; Safety; BRAIN GLUCOSE-METABOLISM; HUMAN MOTOR CORTEX; CONTROLLED-TRIAL; DOUBLE-BLIND; PSYCHIATRIC-DISORDERS; SYMPTOMATOLOGY IDS; INVENTORY; POLARIZATION; EFFICACY; SCALE;
D O I
10.1016/j.jad.2011.05.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Several recent trials have reported transcranial direct current stimulation (tDCS) to be effective in treating depression, though the relative benefits of different electrode montages remain unexplored. Whereas all recent studies have used a bifrontal (BF) electrode montage, studies published in the 1960s and 1970s placed one electrode in an extracephalic position, with some positive reports of efficacy. This study investigated the efficacy and safety of tDCS given with a fronto-extracephalic (F-EX) montage. Methods: 2 mA tDCS was administered for 20 min every weekday over four weeks in 11 participants with a Major Depressive Episode who had previously shown inadequate response to, or relapsed following, a course of BF tDCS. For F-EX tDCS the anode was placed on the left dorsolateral prefrontal cortex and the cathode on the right upper arm. Depression severity and neuropsychological function were assessed before and after the treatment course. Antidepressant response was compared across an equivalent treatment period for both montages. Results: F-EX tDCS was shown to be safe and well tolerated. Depression ratings improved after acute treatment on the Montgomery Asberg Depression Rating Scale (p<0.001). Participants showed greater initial treatment response with F-EX tDCS than with BF tDCS (p<0.001). Limitations: This was an open label pilot study. The two comparison treatments were applied consecutively. Conclusion: F-EX tDCS appears to be safe and to have antidepressant effects, and may lead to more rapid improvement than tDCS given with a BF montage. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:459 / 463
页数:5
相关论文
共 50 条
  • [21] Augmenting Transcranial Direct Current Stimulation With D-Cycloserine for Depression A Pilot study
    Chan, Herng-Nieng
    Alonzo, Angelo
    Martin, Donel M.
    Mitchell, Philip B.
    Sachdev, Perminder
    Loo, Colleen K.
    JOURNAL OF ECT, 2013, 29 (03) : 196 - 200
  • [22] Delayed effect of bifrontal transcranial direct current stimulation in patients with treatment-resistant depression: a pilot study
    Li, Min-Shan
    Du, Xiang-Dong
    Chu, Hsiao-Chi
    Liao, Yen-Ying
    Pan, Wen
    Li, Zhe
    Hung, Galen Chin-Lun
    BMC PSYCHIATRY, 2019, 19 (1)
  • [23] Effects of transcranial direct current stimulation for treating depression: A modeling study
    Csifcsak, Gabor
    Boayue, Nya Mehnwolo
    Puonti, Oula
    Thielscher, Axel
    Mittner, Matthias
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 234 : 164 - 173
  • [24] A Prospective Open-Label Pilot Study of Transcranial Direct Current Stimulation in High-Functioning Autistic Patients with a Dysexecutive Syndrome
    Rotharmel, Maud
    Moulier, Virginie
    Vasse, Marianne
    Isaac, Clemence
    Faerber, Mathieu
    Bendib, Bilal
    Mirea-Grivel, Iris
    Opolczynski, Gaelle
    Rosier, Antoine
    Guillin, Olivier
    NEUROPSYCHOBIOLOGY, 2019, 78 (04) : 189 - 199
  • [25] Treatment of depression with transcranial direct current stimulation (tDCS): A Review
    Nitsche, Michael A.
    Boggio, Paulo S.
    Fregni, Felipe
    Pascual-Leone, Alvaro
    EXPERIMENTAL NEUROLOGY, 2009, 219 (01) : 14 - 19
  • [26] A pilot, open-label investigation of the efficacy of glucosamine for the treatment of major depression
    Kumar, P. N. Suresh
    Sharma, Abhay
    Andrade, Chittaranjan
    ASIAN JOURNAL OF PSYCHIATRY, 2020, 52
  • [27] The Efficacy, Safety, and Tolerability of Probiotics on Depression: Clinical Results From an Open-Label Pilot Study
    Wallace, Caroline J. K.
    Milev, Roumen V.
    FRONTIERS IN PSYCHIATRY, 2021, 12
  • [28] Agomelatine as monotherapy for major depression: an outpatient, open-label study
    Pecenak, Jan
    Novotny, Vladimir
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 1595 - 1604
  • [29] Transcranial Direct Current Stimulation for the Treatment of Depression: a Comprehensive Review of the Recent Advances
    Yadollahpour, Ali
    Jalilifar, Mostafa
    Rashidi, Samaneh
    INTERNATIONAL JOURNAL OF MENTAL HEALTH AND ADDICTION, 2017, 15 (02) : 434 - 443
  • [30] Hospital production cost of transcranial direct current stimulation (tDCS) in the treatment of depression
    Sauvaget, Anne
    Tostivint, Agathe
    Etcheverrigaray, Francois
    Pichot, Anne
    Dert, Cecile
    Schirr-Bonnais, Solene
    Clouet, Johann
    Sellal, Olivier
    Mauduit, Nicolas
    Leux, Christophe
    Cabelguen, Clemence
    Bulteau, Samuel
    Riche, Valery-Pierre
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2019, 49 (01): : 11 - 18